Mind & Mood Archive

People who suffer from chronic insomnia are more likely to develop cognitive problems and score lower on thinking and memory tests compared with individuals without chronic insomnia, a 2025 study suggests.

A 2025 study of over 5,600 women and men followed for over 30 years found that following a Mediterranean diet may reduce the risk of Alzheimer’s disease and improve cognitive function. The effect is strongest in people who carry two copies of the Alzheimer’s risk gene APOE4.

A 2025 study suggested that consuming larger amounts of artificial sweeteners such as aspartame and xylitol may be linked to faster declines in memory and thinking skills.

The vast majority of older adults would want to know if they’re in the early stages of Alzheimer’s disease and would want a blood test to learn for certain, according to a 2025 poll. Advances in testing and treatment may fuel this desire for knowledge. There are pros and cons to knowing this information. People with an early Alzheimer’s diagnosis can plan ahead, seek support, and may feel motivated to maintain their health. But the diagnosis may jeopardize their job or insurance coverage, as well as trigger anxiety or depression.

In May 2025, the FDA approved the first blood test to detect the early stages of Alzheimer’s disease. The test looks for several proteins associated with Alzheimer’s disease. About 80% of the time, the blood test is either highly positive or highly negative, a result that’s accurate more than 90% of the time. Doctors expect that the test will soon be covered by insurance. If that happens, the test will become the standard of care for people ages 55 and older with Alzheimer’s signs or symptoms.

A 2025 study suggests that women who score highly on a brain health measurement incorporating physical, lifestyle, social, and emotional factors face lower stroke odds.

A quarter of American adults live with a mental health disorder such as anxiety, depression, obsessive-compulsive disorder, or post-traumatic stress disorder. But more than half don’t seek help. Internal and external barriers may stop them from getting the care they need. Internal barriers are emotions or excuses people make to avoid treatment. External barriers include cost or difficulty finding a provider who can meet someone’s individual needs. To push past obstacles, people can investigate less-expensive mental health programs or reframe guilt-inducing thoughts.

A 2025 study suggests that sleeping nine or more hours nightly is associated with worse cognitive performance, an effect that’s stronger among people with symptoms of depression.

There are currently nine trials of vaccines for Alzheimer’s disease under way. All of them are in people with mild Alzheimer’s or with the pre-Alzheimer’s condition called mild cognitive impairment. All of the vaccines are designed to encourage the immune system to remove protein deposits from the brain. Most experimental vaccines are given by injection; one being tested at Harvard Medical School uses a nasal spray. It will be several years before we know if any of them will work.

A 2025 study suggested that getting the shingles vaccine can significantly reduce the likelihood of developing dementia, especially among women.